Strides Pharma gets USFDA nod to market generic headache drug

The product, which will be marketed by Singapore-based Strides Pharma Inc in the US market, is a generic version of Teva's Fioricet with Codeine capsules, it added.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news